Drugdoctor
9 minutes ago
¦
On October 3, 2024, the Company completed a one-for-sixty reverse stock split of the outstanding shares of its common stock. As of October 17, 2024, as a result of the split and after certain warrant exercises on the Company’s outstanding Series A Warrants, the Company had 1,441,927 Series